-
Biocon recommends a dividend of Rs. 5 per share 2012-04-28 09:38:06
Biocon posts Revenues at Rs 2,148 Crores; EBITDA at Rs 579 Crores; PAT at Rs 338 Crores Commenting on the results, Chairman and Managing Director of Biocon Kiran Mazumdar-Shaw stated, “I am pleased with the overall performance that we have...
Keywords: net licensing income, Research Services & Branded Formulations, Kiran Mazumdar-Shaw, Biocon
Read MoreBreast cancer drug made 25% cheaper! 2016-05-13 10:29:55
Here is a good news for breast cancer patients! The price of a life-saving breast cancer drug named trastuzumab is now capped by the government at Rs 55,800 per injection. This is more than 25% less than Roche's drug Herceptin...
Keywords: cancer drugs, Hepatitis drugs, trastuzumab, Hepatitis drugs
Read More





